Strides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facility
- Source
- The Economic Times - General
- Source link
- https://economictimes.indiatimes.com/markets/stocks/news/strides-pharma-science-shares-jump-9-after-usfda-eir-for-bengaluru-facility/articleshow/133365447.cms
- Published
- 2026-08-20 05:39:25
- Discovered by ProcIntel
- 2026-08-20 08:23:44
- Category
- Procurement & Supply Chain News
- Geography
- India
- Organisations
- —
- Review status
- Pending
- Record type
- REAL
Summary
Strides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru facility, concluding a recent cGMP inspection. The inspection ended with five observations, which the company addressed through corrective actions. The regulatory closure offers relief after the stock’s recent weakness.
Procurement Relevance Gate
FAIL
— score 7.0/100 — evaluated 2026-08-20 08:23:44
Only geographic exposure matched — no substantive content indicator, so this cannot pass alone.
- geographic_exposure (weight 8) — matched on "1 linked geography"
Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Not Assessed — this Signal did not pass the Procurement Relevance Gate, or is fictional/excluded test data.